These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10826962)

  • 21. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding the 43C9 class of catalytic antibodies using a chain-shuffling approach.
    Miller GP; Posner BA; Benkovic SJ
    Bioorg Med Chem; 1997 Mar; 5(3):581-90. PubMed ID: 9113336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain.
    Hifumi E; Nonaka T; Taguchi H; Uda T
    Sci Rep; 2022 Nov; 12(1):19185. PubMed ID: 36357546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiotypic mimicry of a catalytic antibody active site.
    Johnson G; Moore SW
    Mol Immunol; 2002 Oct; 39(5-6):273-88. PubMed ID: 12220886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of catalytic antibody activity by protease processing.
    Ohara K; Munakata H; Hifumi E; Uda T; Matsuura K
    Biochem Biophys Res Commun; 2004 Mar; 315(3):612-6. PubMed ID: 14975745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered cleavage site preference of a proteolytic antibody light chain induced by denaturation.
    Sun M; Paul S
    FEBS Lett; 1997 May; 407(3):289-90. PubMed ID: 9175870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A catalysis-based selection for peroxidase antibodies with increased activity.
    Yin J; Mills JH; Schultz PG
    J Am Chem Soc; 2004 Mar; 126(10):3006-7. PubMed ID: 15012103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissection of an antibody-catalyzed reaction.
    Stewart JD; Krebs JF; Siuzdak G; Berdis AJ; Smithrud DB; Benkovic SJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7404-9. PubMed ID: 8052597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theory of proteolytic antibody occurrence.
    Paul S; Nishiyama Y; Planque S; Taguchi H
    Immunol Lett; 2006 Feb; 103(1):8-16. PubMed ID: 16290203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and expression of a single-chain catalytic antibody that acts as a glutathione peroxidase mimic with high catalytic efficiency.
    Ren X; Gao S; You D; Huang H; Liu Z; Mu Y; Liu J; Zhang Y; Yan G; Luo G; Yang T; Shen J
    Biochem J; 2001 Oct; 359(Pt 2):369-74. PubMed ID: 11583583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
    Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J
    J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalytic antibodies: evolution of protein function in real time.
    Lerner RA; Janda KD
    EXS; 1995; 73():121-38. PubMed ID: 7579971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-Mediated Catalysis in Infection and Immunity.
    Bowen A; Wear M; Casadevall A
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-Directed Chemical Mutations on Abzymes: Large Rate Accelerations in the Catalysis by Exchanging the Functionalized Small Nonprotein Components.
    Ishikawa F; Shirahashi M; Hayakawa H; Yamaguchi A; Hirokawa T; Tsumuraya T; Fujii I
    ACS Chem Biol; 2016 Oct; 11(10):2803-2811. PubMed ID: 27552288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.